All stock lists
Unlock the score
Electra Therapeutics, Inc. (NASDAQ:ETRA)
US · Delayed Price · Currency is USD
Healthcare · Medical - Pharmaceuticals
8.38-0.33 (-3.78%)
Insider Score
/ 100
ETRA Insider Score
Electra Therapeutics, Inc. has a live Insider Score.
Scored on 4 qualifying trades from 2 insiders in the last 90 days.
ETRA Stock Insider Trading Activity
ETRA stock’s insider trading shows 4 purchases for an estimated $40.00M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days4 qualifying buys2 insiders$40.00M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Parry Graham Other | Converted | 85,504 | — | — | New | 85,504 | Sep 21, 2026 | — | Form 4 |
| Koe Gary S. Other | Converted | 63,656 | — | — | New | 63,656 | Sep 21, 2026 | — | Form 4 |
| Dong Quehuong (Kathy) CEO | Converted | 455,484 | — | — | New | 455,484 | Sep 21, 2026 | — | Form 4 |
| Stagliano Nancy Director | Converted | 255,635 | — | — | New | 255,635 | Sep 21, 2026 | — | Form 4 |
| GORDON CARL L Director | Converted | 2,002,310 | — | — | New | 2,002,310 | Sep 21, 2026 | — | Form 4 |
| GORDON CARL L Director | Converted | 1,087,934 | — | — | 54.3% | 3,090,244 | Sep 21, 2026 | — | Form 4 |
| GORDON CARL L Director | Converted | 1,703,314 | — | — | 55.1% | 4,793,558 | Sep 21, 2026 | — | Form 4 |
| GORDON CARL L Director | Buy | 333,333 | $15.00 | $5.00M | 7.0% | 5,126,891 | Sep 21, 2026 | BFirst BuyBig Buy | Form 4 |
| GORDON CARL L Director | Converted | 758,279 | — | — | New | 758,279 | Sep 21, 2026 | — | Form 4 |
| GORDON CARL L Director | Buy | 1,000,000 | $15.00 | $15.00M | 132% | 1,758,279 | Sep 21, 2026 | A+First BuyStake Doubler | Form 4 |
| ORBIMED ADVISORS LLC Director | Converted | 2,002,310 | — | — | New | 2,002,310 | Sep 21, 2026 | — | Form 4 |
| ORBIMED ADVISORS LLC Director | Converted | 1,087,934 | — | — | 54.3% | 3,090,244 | Sep 21, 2026 | — | Form 4 |
| ORBIMED ADVISORS LLC Director | Converted | 1,703,314 | — | — | 55.1% | 4,793,558 | Sep 21, 2026 | — | Form 4 |
| ORBIMED ADVISORS LLC Director | Buy | 333,333 | $15.00 | $5.00M | 7.0% | 5,126,891 | Sep 21, 2026 | CFirst BuyBig Buy | Form 4 |
| ORBIMED ADVISORS LLC Director | Converted | 758,279 | — | — | New | 758,279 | Sep 21, 2026 | — | Form 4 |
| ORBIMED ADVISORS LLC Director | Buy | 1,000,000 | $15.00 | $15.00M | 132% | 1,758,279 | Sep 21, 2026 | AFirst BuyStake Doubler | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Converted (C) — Conversion of a derivative security into shares
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.